Skip to content

EV / EBITDA at other companies

Abbott logo
AbbottABT
18.9×-4.1×
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.8×+4.2×
Stryker logo
StrykerSYK
22.1×-11.8×
Edwards Lifesciences logo
Edwards LifesciencesEW
29.5×+4.1×
Medtronic logo
MedtronicMDT
13.9×-1.5×
STERIS logo
STERISSTE
14.7×-3.5×

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Calculated from Boston Scientific’s reported figures.

Based on the most recent quarter.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's EV / EBITDA?
Boston Scientific (BSX) reported EV / EBITDA of 28.3× in Q4 2025.
How has Boston Scientific's EV / EBITDA changed year-over-year?
Boston Scientific's EV / EBITDA decreased by 23.1% year-over-year, from 36.8× to 28.3×.
What is the long-term trend for Boston Scientific's EV / EBITDA?
Over 3 years (2022 to 2025), Boston Scientific's EV / EBITDA has grown at a 8.6% compound annual growth rate (CAGR), from 106.7× to 136.6×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.